Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Macey

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Nuclear Medicine and Biology|July 1, 1997
Practical determination of organ S values for individual patients for therapyS Shen, G L DeNardo, D J Macey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Pharmacokinetics, dosimetry and toxicity of holmium-166-DOTMP for bone marrow ablation in multiple myelomaJ E Bayouth, D J Macey, L P Kasi, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1985
Requirements for a treatment planning system for radioimmunotherapyG L DeNardo, A Raventos, H H Hines, et al.
Medical Physics|October 1, 1995
Improved conjugate view quantitation of I-131 by subtraction of scatter and septal penetration events with a triple energy window methodD J Macey, E J Grant, J E Bayouth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemiaG L DeNardo, S J DeNardo, S Shen, et al.
Nuclear Medicine Communications|July 1, 1993
Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignanciesG L DeNardo, M A Mahe, S J DeNardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancerR F Meredith, M B Khazaeli, D J Macey, et al.
Medical Physics|March 1, 1993
Dosimetry of solid tumorsR F Meredith, T K Johnson, G Plott, et al.
The International Journal of Biological Markers|January 1, 1987
Treatment of a patient with B cell lymphoma by I-131 LYM-1 monoclonal antibodiesS J DeNardo, G L DeNardo, L F O'Grady, et al.
Biology of Metals|January 1, 1991
Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin ET G St Pierre, K C Tran, J Webb, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Nuclear Medicine and Biology|July 1, 1997
Practical determination of organ S values for individual patients for therapyS Shen, G L DeNardo, D J Macey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Pharmacokinetics, dosimetry and toxicity of holmium-166-DOTMP for bone marrow ablation in multiple myelomaJ E Bayouth, D J Macey, L P Kasi, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1985
Requirements for a treatment planning system for radioimmunotherapyG L DeNardo, A Raventos, H H Hines, et al.
Medical Physics|October 1, 1995
Improved conjugate view quantitation of I-131 by subtraction of scatter and septal penetration events with a triple energy window methodD J Macey, E J Grant, J E Bayouth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemiaG L DeNardo, S J DeNardo, S Shen, et al.
Nuclear Medicine Communications|July 1, 1993
Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignanciesG L DeNardo, M A Mahe, S J DeNardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancerR F Meredith, M B Khazaeli, D J Macey, et al.
Medical Physics|March 1, 1993
Dosimetry of solid tumorsR F Meredith, T K Johnson, G Plott, et al.
The International Journal of Biological Markers|January 1, 1987
Treatment of a patient with B cell lymphoma by I-131 LYM-1 monoclonal antibodiesS J DeNardo, G L DeNardo, L F O'Grady, et al.
Biology of Metals|January 1, 1991
Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin ET G St Pierre, K C Tran, J Webb, et al.
Pageof 8